A new type of anti-epilepsy medication that selectively targets proteins in the brain that control excitability may significantly reduce seizure frequency in people whose recurrent seizures have been resistant to even the latest medications, new research suggests.
- Choice of seizure drug for brain tumor patients may affect survivalWed, 31 Aug 2011, 22:42:26 EDT
- Pivotal trial data demonstrate Neuropace RNS system reduced seizures in people with epilepsyWed, 9 Dec 2009, 11:57:51 EST
- Adjunctive rufinamide reduces refractory partial-onset seizuresFri, 1 Oct 2010, 6:09:46 EDT
- Deep brain stimulation reduces epileptic seizures in patients with refractory partial and secondarily generalized seizuresThu, 18 Mar 2010, 0:25:15 EDT
- New research suggests common anti-seizure medications may increase risk of cardiovascular problemsWed, 18 Mar 2009, 11:53:55 EDT